1800 202 8726
Fertility & treatment

Can You Breastfeed — While on Targeted Therapy?

Most targeted therapy drugs pass into breast milk in concentrations that can harm your baby. Breastfeeding is not safe during treatment — and not immediately after stopping. How long you need to wait depends entirely on which drug you are on.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026

  • Not safe during treatment — Targeted therapy drugs reach breast milk and expose your baby to active cancer medicine.
  • Washout period is drug-specific — Your oncologist calculates it from your drug's half-life — there is no single number that applies to every treatment.
  • Pumping does not make milk safe to feed — Expressing and discarding removes the milk but not the drug from your body.
  • Fertility preservation has a short window — Egg or embryo freezing takes 10–14 days of preparation. If you want to preserve fertility, raise it today — before treatment starts.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Breastfeeding is not safe while you are on targeted therapy, and it is not safe for a washout period after your last dose. How long that washout is depends on your specific drug — your oncologist will calculate it from the drug's half-life. If fertility preservation matters to you, raise it now, before treatment begins.

Why is breastfeeding not safe on targeted therapy?

Targeted therapy drugs — including tyrosine kinase inhibitors taken as daily tablets and many monoclonal antibodies — are detectable in breast milk. Your baby would receive an active cancer drug with every feed.

These drugs interfere with specific molecular signalling pathways. Those same pathways are active in an infant's developing organs, and the effects of drug exposure at that stage of development are largely unknown.

ASCO, NCCN and ESMO guidance is consistent: breastfeeding should not happen during targeted therapy. It should not resume until a drug-specific washout period after the final dose has passed and your oncologist has confirmed this explicitly.

What are your options for feeding your baby during and after treatment?

Breastfeeding during treatmentExpressing and discarding (pump and dump)Breastfeeding after washout
Baby's drug exposureYes — drug passes through milkNone — milk is not fed to babyShould be none — if washout is confirmed complete
Milk supplyMaintainedMaintained if you pump every 3–4 hours regularlyMay return — but not guaranteed after a long gap without stimulation
Guidance from ASCO and NCCNNot recommendedPumping only to preserve future supply — not as a feeding route for your babyPossible — requires explicit confirmation from your oncologist before the first feed
Key considerationNot safe for your babyDemanding alongside treatment; all expressed milk is discardedWashout must be drug-specific and confirmed — do not assume enough time has passed

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What should you tell and ask your team before treatment starts?

  • Tell your oncologist you are currently breastfeeding or have recently stopped — this is relevant to treatment timing.
  • Ask directly: 'What is the washout period for this specific drug before breastfeeding can be considered again?'
  • Ask whether pumping and discarding throughout treatment is realistic for your situation, if preserving future milk supply matters to you.
  • If fertility preservation is a priority, ask for an immediate referral to a reproductive specialist — ovarian stimulation takes 10–14 days and must happen before treatment starts.
  • Ask your baby's paediatrician about formula options — they can advise on the right formula for your baby's age and guide the transition.
  • Ask whether medicines you will take for side effects — for nausea, pain or infection — also pass into breast milk, in case you plan to resume feeding after the washout period.

Did you know?

Small-molecule targeted therapy tablets — the oral TKIs taken as daily medicine — can reach breast milk even when the mother has no visible side effects and feels completely well.

Larger antibody drugs reach milk in lower concentrations because of their molecular size, but for most drugs used in cancer treatment, the evidence in humans is too limited to rule out harm to a nursing infant.

Source: LactMed, U.S. National Library of Medicine; ASCO Clinical Practice Guideline on Management of Cancer During Pregnancy

Questions families ask about breastfeeding and targeted therapy

Can pumping and discarding keep my milk supply for when treatment ends?

In principle, yes — regular pumping signals the body to keep producing milk, even if that milk is discarded rather than fed to your baby. In practice this means pumping every 3–4 hours, including through the night, for the full duration of treatment and the washout period after. That is a significant demand alongside treatment side effects and recovery. Whether it is worth attempting depends on how long treatment is expected to last, how important returning to breastfeeding is to you, and what you can realistically sustain. These are genuine questions to work through with a lactation consultant and your oncologist before you commit to either approach.

How long is the washout period after my last dose?

There is no single answer that applies to all targeted therapies, and this is one of the most important questions to ask your oncologist directly. Washout is calculated from your drug's half-life — the time it takes for the concentration in your body to halve. A full washout is generally taken as five half-lives. For some drugs this resolves in a matter of days; for others, particularly those that accumulate in tissue or have active breakdown products, it can be several weeks. Your oncologist or clinical pharmacist will give you the figure that applies to your specific drug and regimen. Do not assume the washout is complete without an explicit confirmation.

Will my milk supply come back after the washout period?

It depends on how long treatment lasted and whether you pumped throughout. Milk supply is driven by stimulation — if the breast has not been regularly stimulated for several months, production usually diminishes and may not return fully, or at all. Some people do successfully re-lactate after a gap, with sustained effort and lactation support. The honest answer is that it is not guaranteed, and the longer the gap without stimulation, the lower the likelihood. A lactation consultant can tell you what is realistic for your specific situation, rather than giving you a general estimate.

I want to preserve fertility before starting treatment — is there still time?

Egg or embryo freezing requires ovarian stimulation, which takes approximately 10–14 days. If you have just been diagnosed and treatment does not need to start for at least two to three weeks, there may still be time — but the referral needs to happen today, not at your next appointment. Some situations are too urgent to allow stimulation before treatment starts. In that case, a reproductive specialist can discuss alternatives such as ovarian tissue freezing. Tell your oncologist that fertility preservation is a priority for you now, so the window can be assessed while it still exists.

My baby is only a few weeks old. How do I manage this?

This is one of the most difficult situations in oncology care, and there is no answer that does not involve loss. Your baby will need to transition to formula, and the earlier that conversation happens with your paediatrician, the smoother it tends to be for the baby. For you, stopping breastfeeding at a few weeks postpartum — alongside a cancer diagnosis and the start of treatment — is a genuine grief, not a practical inconvenience. Many people find that naming it as such helps. Ask your oncology team whether a social worker or counsellor is available; you are not managing a logistics problem alone.

Does stopping breastfeeding affect my cancer or its treatment?

Stopping breastfeeding does not worsen cancer outcomes or reduce how well targeted therapy works. There is no treatment reason to continue breastfeeding. The concern runs in the other direction — continuing during treatment affects your baby, not your treatment outcome. Hormonal changes when milk supply stops are temporary. If you are on a hormone-sensitive treatment your oncologist may want to note the timing, so tell your team when you stop. That information belongs in your medical record.

Explore 113 more Family, Fertility, Diet & Emotional Wellbeing topics

All Family, Fertility, Diet & Emotional Wellbeing →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is any targeted therapy safe to take while breastfeeding?

No targeted therapy currently used in cancer treatment has been established as safe for a breastfeeding infant. For many drugs the data on breast milk concentrations is very limited — which itself is a reason for caution, not reassurance. The consistent guidance from NCCN, ASCO and ESMO is to avoid breastfeeding during targeted therapy. Your oncologist or clinical pharmacist can tell you what is specifically known about your drug, but the default recommendation does not change.

Can I take a break from treatment to breastfeed?

Some people ask this, and it is a question your oncologist needs to answer for your specific situation — not one with a general answer. Whether a planned break is possible depends on your cancer type, how your disease is behaving, and what the risks of a gap in treatment would be. For some slowly progressing cancers on maintenance therapy it may be discussable; for many others it is not advisable. Raise it openly with your oncologist. They cannot weigh something they do not know matters to you.

Will formula feeding harm my baby's development?

No. Modern infant formula is nutritionally complete and appropriate for healthy full-term infants. Stopping breastfeeding because of cancer treatment is not harming your baby — it is protecting them from drug exposure through milk. Your baby's paediatrician can advise on the right formula for their age and help guide the transition from breast to bottle if needed.

I am on trastuzumab — is that different from tablet targeted therapies?

Trastuzumab is a large-molecule monoclonal antibody rather than a small-molecule oral drug, and its size means it reaches breast milk differently. Some data suggests IgG antibodies pass into milk in relatively low concentrations. However, this does not mean breastfeeding during trastuzumab is established as safe — the human data is limited, and many people on trastuzumab are also on other agents. The standard recommendation is to avoid breastfeeding during treatment and for the drug-specific washout period after. Ask your oncologist for the figure that applies to your regimen.

What if formula is too expensive or hard to get in our area?

Tell your oncologist or social worker that access or cost is a barrier. Many hospitals, cancer programmes and state health schemes in Telangana and Andhra Pradesh have support mechanisms, and oncology social workers can often help connect families with infant nutrition resources. Your baby's paediatrician may also know of locally available support. Raise it directly with your team rather than managing it alone — it is a practical problem with practical solutions.

When exactly can I start breastfeeding again after treatment ends?

Not until your oncologist has confirmed that the washout period for your specific drug has passed and that you are not about to restart treatment. The washout begins from your last dose, not from when you start feeling well. Your oncologist or pharmacist will give you the exact figure for your drug. If you have maintained your milk supply by pumping and the washout is complete, breastfeeding may be possible — but get explicit confirmation before the first feed, not an assumption based on how much time has passed.

Call now Book free consultation